Tirzepatide (Mounjaro & Zepbound) Though not strictly a GLP-1, it also activates GIP receptors, leading to even more pronounced weight loss
Furthermore, what if employers that offer self-insured plans to their employees and dependents follow suit
Low B12 levels can cause symptoms like fatigue, dizziness, anaemia, nerve-related tingling in the hands and feet, muscle weakness, memory and concentration problems, depression, and, in severe cases, dementia. The most commonly used injectable form of vitamin B12 is hydroxocobalamine, typically provided by a general practitioner for severe B12 deficiency
Adherence to GLP-1s better than earlier reported Source: Marshall, LZ et al Trends in 1-year persistence and adherence among initiators of high-potency, weight lossindicated glucagon-like peptide 1 receptor agonists, J Man Care Pharm February 27, 2026 Multiple studies have reported low adherence to GLP-1 medications to treat obesity, and some have cited this as a reason why employers should not cover these medications